This medicinal product is subject to additional monitoring. This will allow quick identification of
new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
See section 4.8 for how to report adverse reactions.
1. NAME OF THE MEDICINAL PRODUCT
Striverdi Respimat 2.5 microgram, solution for inhalation
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
The delivered dose is 2.5 microgram Olodaterol (as hydrochloride) per puff.
The delivered dose is the dose which is available for the patient after passing the mouthpiece.
For the full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Solution for inhalation
Clear, colourless, solution for inhalation
4. CLINICAL PARTICULARS
4.1 Therapeutic indications
Striverdi Respimat is indicated as a maintenance bronchodilator treatment in patients with chronic
obstructive pulmonary disease (COPD).